Advertisement

EUROPEAN Device Guide / Drug-Eluting Stents

Company Name Product Name Drug Delivered Material Used Polymer Type Maximum Guidewire Size (inch) Introducer Size (F) Stent Diameter (mm) Stent Length (mm) Delivery System Length (cm) CE Mark Indications
iVascular Angiolite BTK Sirolimus Cobalt chromium (CoCr L605) Biostable fluorinated acrylate 0.014 5 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 9, 14, 16, 19, 24, 29, 34, 39 142 Indicated for treating chronic and acute arterial lesions in the lower limbs below the knee, as well as popliteal and infrapopliteal lesions with reference vessel diameters between 2–4.5 mm, with the aim of increasing the internal diameter of an artery and consequently improving blood flow in the following cases: severe claudication and critical limb ischemia
Biosensors International BioMatrix Flex BTK Drug-Eluting Peripheral Stent Biolimus A9 pharmaceutical ingredient Stainless steel Biodegradable polymer coating 15.6 μg/mm stent length 0.014 5, 6 2.25, 2.5, 2.75, 3, 3.5, 4 8, 11, 14, 18, 24, 28, 33, 36 142 Indicated for improving infrapopliteal luminal diameter for the treatment of occlusive lesions BTK and above the ankle that lead to severe claudication or CLI; treated infrapopliteal arteries must have a reference diameter ranging between 2.25–4 mm
Alvimedica Cre8 BTK Amphilimus (sirolimus + fatty acid) Cobalt chromium Polymer free 0.014 4 2.25–4.5 8–46 142 Peripheral/BTK
Boston Scientific Corporation Eluvia Drug-Eluting Vascular Stent System Paclitaxel Nitinol Polymer-based technology with proven biocompatibility 0.035 6 6–7 40, 60, 80, 100, 120, 150 75, 130 SFA and/or PPA
Abbott Xience Prime BTK Everolimus Cobalt chromium Fluorinated copolymer 0.014 4 2.5, 3, 3.5, 4 28, 38 143 Indicated for improving peripheral luminal diameter in the following: the treatment of severe claudication or CLI due to infrapopliteal occlusive lesions
Cook Medical Zilver PTX Paclitaxel Nitinol Polymer free 0.035 6 5–8 40, 60, 80, 100, 120, 140 80, 125 Above-the-knee femoropopliteal arteries

Advertisement